GMP Compliance Construction as the Core Competitiveness of the Pharmaceutical Industry

The pharmaceutical industry is entering a new stage where high-quality development and globalization advance in parallel. Particularly in Asia, more and more countries are accelerating the establishment of GMP (Good Manufacturing Practice) systems to align their pharmaceutical quality standards with international benchmarks. For enterprises seeking breakthroughs in pharmaceutical exports, collaborative R&D, and international certification, GMP compliance has become a key measure of competitiveness.

In practice, many emerging-market companies face multiple challenges when building GMP-compliant factories, including design standards, equipment selection, quality control, and software systems. This process not only requires significant financial investment but also calls for mature consulting support and the adoption of cross-border expertise.

Chiundo Co., Ltd., leveraging its accumulated knowledge of Japan’s advanced GMP practices and its successful consulting projects in India and Laos, provides clients with end-to-end services—from facility planning and factory construction to laboratory integration. The company is well-versed in international pharmaceutical standards and helps enterprises effectively mitigate compliance risks while accelerating the establishment of production bases.

Looking ahead, international pharmaceutical companies will need to achieve breakthroughs not only in production capacity but also in GMP compliance and international certification capabilities. As a bridge for cross-border cooperation, Chiundo is committed to helping more Asian enterprises integrate into the global pharmaceutical supply chain.